Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1420 ARTÍCULOS , VIENDO DEL 601 AL 615

Orexin, Sleep, and Cognition in Alzheimer Disease: Non-REM Oscillatory Activity and Neural Resilience

Paez A, Piñol-Ripoll G, Carnes-Vendrell A, Dakterzada F, Barbé F, Zetterberg H, Dang-Vu TT.

Neurology. 2026 Aug 11;107(3):e218307. doi: 10.1212/WNL.0000000000218307. Epub 2026 Jul 14.

The past, present, and future of Alzheimer's disease-part 3: the future

Nitrini R, Takada LT, Brucki SMD.

Arq Neuropsiquiatr. 2026 Jun;84(6):1-10. doi: 10.1055/s-0046-1824435. Epub 2026 Jul 14.

Salivary Biomarkers in Alzheimer's Disease: Emerging Diagnostic Tools and Their Association with Periodontal Disease

Świątek A, Kusiak A, Maj A.

Int J Mol Sci. 2026 Jun 30;27(13):5888. doi: 10.3390/ijms27135888.

Handwriting as a Biomarker for Early Detection of Parkinson's and Alzheimer's Diseases: A Comprehensive Guide for Researchers

Bensefia A, Al Hashlamoun N.

Sensors (Basel). 2026 Jul 2;26(13):4190. doi: 10.3390/s26134190.

Predictive value of plasma p-tau217 for Alzheimer's dementia compared to other blood-based biomarkers

Trares K, Duman D, Beyer L, Michaelian JC, Stocker H, Holleczek B, Beyreuther K, Schöttker B, Gerwert K, Brenner H.

EMBO Mol Med. 2026 Aug;18(8):3374-3388. doi: 10.1038/s44321-026-00483-9. Epub 2026 Jul 16.

Baseline and placebo-related imaging, cerebrospinal fluid, plasma biomarker, and cognitive findings in unimpaired PSEN1 E280A mutation carriers and non-carriers in the Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia Trial

Bittner T, Lopera F, Rios-Romenets S, Schiffman C, Clayton D, Hibar D, Kollmorgen G, Dolton M, Poon V, Nguyen J, Giraldo-Chica M, Acosta-Baena N, Espinosa A, Villegas G, Muñoz C, Serna L, Alvarez S, Protas H, Luo J, Sohankar J, Chen Y, Ghisays V, Malek-Ahmadi M, Ashton NJ, Denkinger MN, Cai Y, Xu YR, Ostaszewski B, Selkoe DJ, Alexander RC, Quiroz YT, Su Y, Chen K, Doody RS, Langbaum JB, Tariot PN, Sink KM, Reiman EM.

EBioMedicine. 2026 Aug;130:106390. doi: 10.1016/j.ebiom.2026.106390. Epub 2026 Jul 17.

Neurotheranostics in Alzheimer's Disease: Current concepts and experimental strategies

Yanagisawa D, Ohgita T, Kawashima H, Yoshikawa H, Saito H, Tooyama I, Takata K.

Pharmacol Ther. 2026 Oct;286:109084. doi: 10.1016/j.pharmthera.2026.109084. Epub 2026 Jul 19.

Recent breakthroughs in blood-based biomarkers of Alzheimer disease: opportunities and challenges in older adults

Dyer AH, Dolphin H, Roitto HM, O'Connor A, Welsh TJ, Kennelly SP.

Age Ageing. 2026 Jul 2;55(7):afag213. doi: 10.1093/ageing/afag213.

Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias

Bellomo G, Vermunt L, In 't Veld S, Doecke JD, Hok-A-Hin YS, Veverová K, Houtkamp IM, Alcolea D, Halbgebauer S, Quesada C, Mattsson N, Martinez-Castillo M, López-Martínez MJ, Rábano A, Boonkamp L, Fowler C, Fortea J, Gaetani L, Toja A, Pijnenburg Y, Lemstra A, van der Flier WM, Sánchez-Juan P, Hort J, Otto M, Anderl-Staub S, Sieben A, de Viel B, Engelborghs S, Hansson O, Masters C, Lleó A, Parnetti L, Teunissen CE, Del Campo M.

Nat Aging. 2026 Aug;6(8):1717-1732. doi: 10.1038/s43587-026-01162-7. Epub 2026 Jul 20.

Considerations in Alzheimer's Disease in Women

Just C, Seibert K, Chan C, Maldonado-Correa C, Jones D.

Curr Neurol Neurosci Rep. 2026 Jul 23;26(1):36. doi: 10.1007/s11910-026-01504-3.

Efficacy Measures Used in Alzheimer Disease Clinical Trials Between 2015 and 2025: A Systematic Review

Li C, Fu M, Berg K, Wallach J, Ling K, Wei R, Shi L, Ross J, Guan X.

Neurology. 2026 Aug 25;107(4):e218373. doi: 10.1212/WNL.0000000000218373. Epub 2026 Jul 23.

Role of Exercise in Cardiovascular Disease and Alzheimer's Disease Comorbidity: A Blood Biomarker Perspective

Lu Y, Xu C, Fu P, Gong L.

Cells. 2026 Jul 17;15(14):1284. doi: 10.3390/cells15141284.

Pharmacological and Clinical Heterogeneity of Anti-Amyloid Monoclonal Antibodies in Early Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Trials

Vamanu A, Mastaleru A, Schreiner TG, Popescu G, Roceanu AM, Cucu AI, Patrascu A, Vulpoi GA, Bilcu RV, Cozma RS, Olariu R, Bistriceanu CE, Covali R, Cuciureanu DI, Ciubotaru A.

Med Sci (Basel). 2026 Jun 23;14(3):337. doi: 10.3390/medsci14030337.

Alzheimer's blood-based biomarkers, incident dementia, and interactions with age, APOE status, and hormone therapy

Mielke MM, Gaussoin SA, Casanova R, Latham LA, Manson JE, Mouton CP, Ng TKS, Rapp SR, Resnick SM, Sachs BC, Saquib N, Shadyab AH, McEvoy LK, LaCroix AZ, Wallace RB, Espeland MA, Chen JC, Hayden KM.

Alzheimers Dement. 2026 Jul;22(7):e71704. doi: 10.1002/alz.71704.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias